@misc{indiciae477b9a86d1b4,
  title = {Outcomes of elacestrant in patients with ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer who received prior endocrine therapy and cyclin-dependent kinase inhibitor in a real-world setting.},
  author = {G Curigliano and M De Laurentiis and N Harbeck and S Kuemmel and J \&\#xc1; Garc\&\#xed;a-S\&\#xe1;enz and R Sanchez Bayona and D Rea and A Okines and B Pistilli and E Sears and J Maitland and S Kloss and T Wasserman and M Ignatiadis},
  year = {2026},
  doi = {10.1016/j.esmoop.2026.108535},
  url = {https://pubmed.ncbi.nlm.nih.gov/42735454/},
  note = {Source identifier: 42735454}
}